IRDs are a group of genetic ophthalmic diseases characterized by visual impairment and represent the leading cause of severe vision loss in persons between 15 and 45 years of age with an estimated incidence of 1 in every 2,000 people (Cideciyan et al. 2019; Cremers et al. 2018).
IRDs are highly heterogeneous and differ in many characteristics such as the onset of disease, varying from first year of life to adulthood; the rate of disease progression; the extent of visual impairment, and the potential involvement of other organ systems.
In 2016, the American Academy of Ophthalmology, in collaboration with IRD experts, published recommendations on clinical assessment of patients with IRDs. To know more about clinical diagnosis, genetic diagnosis and information to educate your patients, please follow this link to AAO recommendations.